PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
121.05%
Net income growth of 121.05% while AXSM is zero at 0.00%. Bruce Berkowitz would see a modest advantage that can compound if well-managed.
473.10%
D&A growth of 473.10% while AXSM is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
20.60%
Deferred tax of 20.60% while AXSM is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-20.60%
Both cut yoy SBC, with AXSM at -0.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
534.15%
Working capital change of 534.15% while AXSM is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
82.02%
AP growth of 82.02% while AXSM is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
107.35%
Growth of 107.35% while AXSM is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-145.76%
Negative yoy while AXSM is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-3.22%
Negative yoy CFO while AXSM is 0.00%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-7359.68%
Negative yoy CapEx while AXSM is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Growth of 100.00% while AXSM is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-7359.68%
We reduce yoy invests while AXSM stands at 0.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
37.62%
Debt repayment growth of 37.62% while AXSM is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
299.00%
Issuance growth of 299.00% while AXSM is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.